L1E-1 Citations (2)

Originally described in: Mek1 alters epidermal growth and differentiation
Scholl FA, Dumesic PA, Khavari PA Cancer Res. 2004 Sep 1;64(17):6035-40 PubMed Journal

---

Articles Citing L1E-1

Articles
The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models. Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, Mazar A, Evens AM. Clin Cancer Res. 2014 Dec 1;20(23):6023-33. doi: 10.1158/1078-0432.CCR-14-1532. Epub 2014 Oct 14. PubMed
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells. Patel H, Mishra R, Wier A, Mokhtarpour N, Merino EJ, Garrett JT. Anticancer Drugs. 2023 Apr 1;34(4):519-531. doi: 10.1097/CAD.0000000000001500. Epub 2023 Feb 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.